Emerging Translational Approaches Targeting Cellular-geospatial Heterogeneity in Cholangiocarcinoma

Description

The recent advances in the cellular and geospatial immuno-genomic heterogeneity of cholangiocarcinoma may impact the future therapeutic approaches for this malignancy. Attendees will review the current and emerging strategies to manage the disease (i.e., treatment options and biomarkers) along with an overview of new findings and insights from new technologies of cellular and geospatial immuno-genomic profiling. In addition, attendees will learn about the utility of clinically relevant patient-derived experimental models toward the goal to achieve precision care of cholangiocarcinoma patients.